Sickle Cell Hemoglobinopathies and Bone Health

Active, not recruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Sickle Cell DiseaseSickle Cell Trait
Interventions
OTHER

Healthy volunteers without SCT

Subjects will undergo bone density evaluation via dual energy x-ray absorptiometry (DEXA) scanning. Subjects will provide a sample of for testing of bone turnover markers, complete blood count, and hemoglobin electrophoresis. Subjects will provide information about their dietary calcium intake and pain burden.

OTHER

Healthy volunteers with SCT

Subjects will undergo bone density evaluation via dual energy x-ray absorptiometry (DEXA) scanning. Subjects will provide a sample of for testing of bone turnover markers, complete blood count, and hemoglobin electrophoresis. Subjects will provide information about their dietary calcium intake and pain burden.

OTHER

Volunteers with SCD

Subjects will undergo bone density evaluation via dual energy x-ray absorptiometry (DEXA) scanning. Subjects will provide a sample of for testing of bone turnover markers, complete blood count, and hemoglobin electrophoresis. Subjects will provide information about their dietary calcium intake and pain burden.

Trial Locations (1)

06030

UConn Health, Farmington

All Listed Sponsors
lead

UConn Health

OTHER

NCT02306993 - Sickle Cell Hemoglobinopathies and Bone Health | Biotech Hunter | Biotech Hunter